                         SEQUENCE LISTING

<110>  THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
 
<120>  METHODS OF USING NEUROKININ-1 RECEPTOR (NK-1R) ANTAGONISTS TO 
       TREAT beta-CORONAVIRUS INFECTION INCLUDING SARS-COV-2 INFECTION 
       AND/OR COVID-19 DISEASE

<130>  517709 CU5331H

<150>  US 63/005,994
<151>  2020-04-06

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  11
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  Substance P

<400>  1

Arg Pro Lys Pro Gln Gln Phe Phe Gly Leu Met 
1               5                   10      


<210>  2
<211>  4
<212>  PRT
<213>  Vesicular stomatitis virus


<220>
<221>  MISC_FEATURE
<222>  (1)..(4)
<223>  fragment of VZV glycoprotein B (gB)

<400>  2

Phe Phe Gly Leu 
1               


<210>  3
<211>  4
<212>  PRT
<213>  Bovine respiratory syncytial virus


<220>
<221>  MISC_FEATURE
<223>  fragment of BRSV fusion protein

<400>  3

Phe Tyr Gly Leu 
1               


<210>  4
<211>  4
<212>  PRT
<213>  Severe acute respiratory syndrome coronavirus 2


<220>
<221>  MISC_FEATURE
<222>  (1)..(4)
<223>  fragement of SARS-CoV-2 ORF 1a/b protein

<400>  4

Tyr Phe Gly Leu 
1               


